• Blog
  • Rheumatoid Arthritis Treatment Market Report

    Rheumatoid Arthritis Treatment Market Report

    Rheumatoid Arthritis Treatment Market Report
    Report code - SRHL236 Delivery - 2 Weeks
    Get Free Sample |
    Play Audio
    Listen
    Global Rheumatoid Arthritis Treatment Market, Dynamics, Market Analysis
    See more...

    Market Insights

    The Global Rheumatoid Arthritis Treatment Market is expected to grow from USD 23.1 billion in 2020 to USD 32.7 billion by 2026 at a CAGR of over 6% during the forecast period.

    Figure: Global Rheumatoid Arthritis Treatment Market Size, 2020-2026 (USD Billion)

    Rheumatoid-Arthritis-Treatment-Market-Forecast

    Wish to get a free sample report? Click Here.

    What is Rheumatoid arthritis?

    Rheumatoid arthritis is an autoimmune and chronic inflammatory disorder that affects the joints. It can also damage other parts of the body including skin, lungs, heart, eyes, and blood vessels. It happens when the immune system attacks the body tissues by mistake and thus, caused inflammation in the joints.

    Key Players

    Key players operating in the global Rheumatoid Arthritis Treatment Market are-

    • Sanofi SA (France),
    • Johnson & Johnson (The U.S),
    • F. Hoffman-La Roche AG (Switzerland),
    • Pfizer Inc. (The U.S),
    • Eli Lilly & Company (The U.S),
    • AbbVie Inc. (The U.S),
    • Sobi Inc. (Sweden),
    • Amgen Inc. (The U.S),
    • UCB S.A. (Belgium), and
    • Bristol-Myers Squibb Company (The U.S).

    Market Dynamics

    The growth of the global rheumatoid arthritis treatment market is primarily driven by the increasing prevalence of arthritis particularly among the geriatric populace across geographies.

    • Increasing consumer awareness is expected to bolster the market growth significantly.
    • Additionally, the growing emphasis on the development of advanced solutions by the market players is projected to propel market growth at a significant rate during the review period.
    • However, the high cost associated with rheumatoid arthritis treatment is likely to affect the market growth.

    Segment Analysis

    Therapy Type Trends

    Based on therapy type, the market has been segmented into symptomatic treatment, intermediate corticosteroid therapies, and disease-modifying antirheumatic drug (DMARD) therapies.

    • The DMARD segment has been further bifurcated into conventional DMARDs and biologic DMARDs.
    • The DMARD segment accounted for the largest market share in 2020 and is projected to grow at the fastest CAGR during the review period due to the increasing adoption of conventional DMARD therapy to treat rheumatoid arthritis.

    Regional Trends

    Geographically, the market in North America accounted for the largest market share in 2020.

    • The market growth can be attributed to expanding geriatric populace and the availability of advanced healthcare infrastructure.
    • The market in Asia-Pacific is expected to register the fastest growth during the review period on account of rising consumer awareness and the growing medical tourism industry in developing countries.

    COVID-19 Impact on Global Rheumatoid Arthritis Treatment Market

    The covid-19 outbreak did affect the growth of the rheumatoid arthritis treatment market negatively due to fear among the people that patients having rheumatoid arthritis are more prone to covid-19 and are likely to face more severe complications. The rheumatoid arthritis patients made significant changes in their medical use amid the covid-19 outbreak and thus, affected the market growth.

    Critical Questions Answered in the Report

    • What are the key trends in the global rheumatoid arthritis treatment market?
    • How the market (and its various sub-segments) has grown in the last five years and what would be the growth rate in the next five years?
    • What is the impact of COVID-19 on global rheumatoid arthritis treatment market?
    • What are the key strategies adopted by the major vendors to lead in the global rheumatoid arthritis treatment market?
    • What is the market share of the top vendors?

    Get full scope of the report. Register Here

    Target Audience

    Here is the list of the group of customers that the market hopes to have the greatest opportunity to convert-

    • Rheumatoid arthritis treatment manufacturers
    • Rheumatoid arthritis treatment suppliers
    • Rheumatoid arthritis treatment distributors
    • Organizations
    • Government bodies

    Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at [email protected].

    Frequently Asked Questions (FAQs)

    The rheumatoid arthritis treatment market size is expected to reach USD 32.7 billion in the foreseeable future.

    Sanofi SA (France), Johnson & Johnson (The U.S), F. Hoffman-La Roche AG (Switzerland), Pfizer Inc. (The U.S), Eli Lilly & Company (The U.S), AbbVie Inc. (The U.S), Sobi Inc. (Sweden), Amgen Inc. (The U.S), UCB S.A. (Belgium) and Bristol-Myers Squibb Company (The U.S) are among the key players in the rheumatoid arthritis treatment market.

    The Rheumatoid Arthritis Treatment Market is expected to witness an impressive growth of 6% CAGR in the coming years.

    North America accounted for the largest share of rheumatoid arthritis treatment market in 2020.

    Asia-pacific is expected to register the fastest growth in the rheumatoid arthritis treatment market in the coming years.

    Rheumatoid arthritis treatment manufacturers, Rheumatoid arthritis treatment suppliers, Rheumatoid arthritis treatment distributors, Organizations, Government bodies are the target audience in the rheumatoid arthritis treatment market.

    Increasing prevalence of arthritis particularly among the geriatric populace across geographies, Increasing consumer awareness, growing emphasis on the development of advanced solutions by the market players are the factors driving the growth of rheumatoid arthritis treatment market.

    •